Market Tracker

01/16 8:21am ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

148.90
Delayed Data
As of Jan 12
 +0.95 / +0.64%
Today’s Change
95.08
Today|||52-Week Range
149.31
+8.74%
Year-to-Date

Today’s Trading

Previous close147.95
Today’s open148.11
Day’s range147.68 - 149.24
Volume166,403
Average volume (3 months)230,637
Market cap$3.1B
Data as of 4:00pm ET, 01/12/2018

Growth & Valuation

Earnings growth (last year)-101.05%
Earnings growth (this year)+41.86%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+51.53%
P/E ratio212.7
Price/Sales19.42
Price/Book9.12

Competitors

 Today’s
change
Today’s
% change
PBHPrestige Brands Hold...-0.11-0.24%
GWPHGW Pharmaceuticals P...-0.56-0.42%
MDCOMedicines Co+0.02+0.07%
CBPOChina Biologic Produ...+3.87+4.99%
Data as of 4:15pm ET, 01/12/2018

Financials

Next reporting dateFebruary 13, 2018
EPS forecast (this quarter)$1.08
Annual revenue (last year)$109.0M
Annual profit (last year)-$2.4M
Net profit margin-2.17%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
San Diego, California

Forecasts